Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions
- PMID: 12623193
- DOI: 10.1016/s0378-5173(03)00009-7
Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions
Abstract
The purpose of this study was to enhance the dissolution rate of artemisinin in order to improve the intestinal absorption characteristics. The effect of: (1) micronisation and (2) formation of solid dispersions with PVPK25 was assessed in an in vitro dissolution system [dissolution medium: water (90%), ethanol (10%) and sodium lauryl sulphate (0.1%)]. Coulter counter analysis was used to measure particle size. X-ray diffraction and DSC were used to analyse the physical state of the powders. Micronisation by means of a jet mill and supercritical fluid technology resulted in a significant decrease in particle size as compared to untreated artemisinin. All powders appeared to be crystalline. The dissolution rate of the micronised forms improved in comparison to the untreated form, but showed no difference in comparison to mechanically ground artemisinin. Solid dispersions of artemisinin with PVPK25 as a carrier were prepared by the solvent method. Both X-ray diffraction and DSC showed that the amorphous state was reached when the amount of PVPK25 was increased to 67%. The dissolution rate of solid dispersions with at least 67% of PVPK25 was significantly improved in comparison to untreated and mechanically ground artemisinin. Modulation of the dissolution rate of artemisinin was obtained by both particle size reduction and formation of solid dispersions. The effect of particle size reduction on the dissolution rate was limited. Solid dispersions could be prepared by using a relatively small amount of PVPK25. The formation of solid dispersions with PVPK25 as a carrier appears to be a promising method to improve the intestinal absorption characteristics of artemisinin.
Copyright 2003 Elsevier Science B.V.
Similar articles
-
Improved physicochemical characteristics of artemisinin-nicotinamide solid dispersions by solvent evaporation and freeze dried methods.Pak J Pharm Sci. 2012 Apr;25(2):447-56. Pak J Pharm Sci. 2012. PMID: 22459476
-
Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone.Arch Pharm Res. 2008 Mar;31(3):390-8. doi: 10.1007/s12272-001-1169-6. Epub 2008 Apr 13. Arch Pharm Res. 2008. PMID: 18409055
-
Improved physicochemical characteristics of artemisinin using succinic acid.Acta Pol Pharm. 2014 May-Jun;71(3):451-62. Acta Pol Pharm. 2014. PMID: 25265825
-
Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.Arch Pharm Res. 2011 May;34(5):757-65. doi: 10.1007/s12272-011-0509-1. Epub 2011 Jun 9. Arch Pharm Res. 2011. PMID: 21656361
-
Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension.J Pharm Pharmacol. 2010 Apr;62(4):413-21. doi: 10.1211/jpp.62.04.0002. J Pharm Pharmacol. 2010. PMID: 20604829
Cited by
-
Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.Adv Healthc Mater. 2017 Aug;6(16):10.1002/adhm.201700433. doi: 10.1002/adhm.201700433. Epub 2017 Jul 28. Adv Healthc Mater. 2017. PMID: 28752598 Free PMC article. Review.
-
Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability.Pharmaceutics. 2019 Feb 3;11(2):67. doi: 10.3390/pharmaceutics11020067. Pharmaceutics. 2019. PMID: 30717471 Free PMC article.
-
Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign.PLoS One. 2018 Jul 9;13(7):e0200218. doi: 10.1371/journal.pone.0200218. eCollection 2018. PLoS One. 2018. PMID: 29985967 Free PMC article.
-
Exploring inclusion complex of an anti-cancer drug (6-MP) with β-cyclodextrin and its binding with CT-DNA for innovative applications in anti-bacterial activity and photostability optimized by computational study.RSC Adv. 2022 Oct 28;12(48):30936-30951. doi: 10.1039/d2ra05072b. eCollection 2022 Oct 27. RSC Adv. 2022. PMID: 36349019 Free PMC article.
-
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.Pharmaceutics. 2018 May 19;10(2):60. doi: 10.3390/pharmaceutics10020060. Pharmaceutics. 2018. PMID: 29783757 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources